Cargando…

Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens

Intracellular bacteria that live in host cell–derived vacuoles are significant causes of human disease. Parasitism of low-density lipoprotein (LDL) cholesterol is essential for many vacuole-adapted bacteria. Acid sphingomyelinase (ASM) influences LDL cholesterol egress from the lysosome. Using funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Cockburn, Chelsea L, Green, Ryan S, Damle, Sheela R, Martin, Rebecca K, Ghahrai, Naomi N, Colonne, Punsiri M, Fullerton, Marissa S, Conrad, Daniel H, Chalfant, Charles E, Voth, Daniel E, Rucks, Elizabeth A, Gilk, Stacey D, Carlyon, Jason A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431796/
https://www.ncbi.nlm.nih.gov/pubmed/30902833
http://dx.doi.org/10.26508/lsa.201800292
_version_ 1783405986728378368
author Cockburn, Chelsea L
Green, Ryan S
Damle, Sheela R
Martin, Rebecca K
Ghahrai, Naomi N
Colonne, Punsiri M
Fullerton, Marissa S
Conrad, Daniel H
Chalfant, Charles E
Voth, Daniel E
Rucks, Elizabeth A
Gilk, Stacey D
Carlyon, Jason A
author_facet Cockburn, Chelsea L
Green, Ryan S
Damle, Sheela R
Martin, Rebecca K
Ghahrai, Naomi N
Colonne, Punsiri M
Fullerton, Marissa S
Conrad, Daniel H
Chalfant, Charles E
Voth, Daniel E
Rucks, Elizabeth A
Gilk, Stacey D
Carlyon, Jason A
author_sort Cockburn, Chelsea L
collection PubMed
description Intracellular bacteria that live in host cell–derived vacuoles are significant causes of human disease. Parasitism of low-density lipoprotein (LDL) cholesterol is essential for many vacuole-adapted bacteria. Acid sphingomyelinase (ASM) influences LDL cholesterol egress from the lysosome. Using functional inhibitors of ASM (FIASMAs), we show that ASM activity is key for infection cycles of vacuole-adapted bacteria that target cholesterol trafficking—Anaplasma phagocytophilum, Coxiella burnetii, Chlamydia trachomatis, and Chlamydia pneumoniae. Vacuole maturation, replication, and infectious progeny generation by A. phagocytophilum, which exclusively hijacks LDL cholesterol, are halted and C. burnetii, for which lysosomal cholesterol accumulation is bactericidal, is killed by FIASMAs. Infection cycles of Chlamydiae, which hijack LDL cholesterol and other lipid sources, are suppressed but less so than A. phagocytophilum or C. burnetii. A. phagocytophilum fails to productively infect ASM(−/−) or FIASMA-treated mice. These findings establish the importance of ASM for infection by intracellular bacteria and identify FIASMAs as potential host-directed therapies for diseases caused by pathogens that manipulate LDL cholesterol.
format Online
Article
Text
id pubmed-6431796
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Life Science Alliance LLC
record_format MEDLINE/PubMed
spelling pubmed-64317962019-03-29 Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens Cockburn, Chelsea L Green, Ryan S Damle, Sheela R Martin, Rebecca K Ghahrai, Naomi N Colonne, Punsiri M Fullerton, Marissa S Conrad, Daniel H Chalfant, Charles E Voth, Daniel E Rucks, Elizabeth A Gilk, Stacey D Carlyon, Jason A Life Sci Alliance Research Articles Intracellular bacteria that live in host cell–derived vacuoles are significant causes of human disease. Parasitism of low-density lipoprotein (LDL) cholesterol is essential for many vacuole-adapted bacteria. Acid sphingomyelinase (ASM) influences LDL cholesterol egress from the lysosome. Using functional inhibitors of ASM (FIASMAs), we show that ASM activity is key for infection cycles of vacuole-adapted bacteria that target cholesterol trafficking—Anaplasma phagocytophilum, Coxiella burnetii, Chlamydia trachomatis, and Chlamydia pneumoniae. Vacuole maturation, replication, and infectious progeny generation by A. phagocytophilum, which exclusively hijacks LDL cholesterol, are halted and C. burnetii, for which lysosomal cholesterol accumulation is bactericidal, is killed by FIASMAs. Infection cycles of Chlamydiae, which hijack LDL cholesterol and other lipid sources, are suppressed but less so than A. phagocytophilum or C. burnetii. A. phagocytophilum fails to productively infect ASM(−/−) or FIASMA-treated mice. These findings establish the importance of ASM for infection by intracellular bacteria and identify FIASMAs as potential host-directed therapies for diseases caused by pathogens that manipulate LDL cholesterol. Life Science Alliance LLC 2019-03-22 /pmc/articles/PMC6431796/ /pubmed/30902833 http://dx.doi.org/10.26508/lsa.201800292 Text en © 2019 Cockburn et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Articles
Cockburn, Chelsea L
Green, Ryan S
Damle, Sheela R
Martin, Rebecca K
Ghahrai, Naomi N
Colonne, Punsiri M
Fullerton, Marissa S
Conrad, Daniel H
Chalfant, Charles E
Voth, Daniel E
Rucks, Elizabeth A
Gilk, Stacey D
Carlyon, Jason A
Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens
title Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens
title_full Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens
title_fullStr Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens
title_full_unstemmed Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens
title_short Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens
title_sort functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431796/
https://www.ncbi.nlm.nih.gov/pubmed/30902833
http://dx.doi.org/10.26508/lsa.201800292
work_keys_str_mv AT cockburnchelseal functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT greenryans functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT damlesheelar functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT martinrebeccak functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT ghahrainaomin functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT colonnepunsirim functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT fullertonmarissas functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT conraddanielh functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT chalfantcharlese functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT vothdaniele functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT ruckselizabetha functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT gilkstaceyd functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens
AT carlyonjasona functionalinhibitionofacidsphingomyelinasedisruptsinfectionbyintracellularbacterialpathogens